Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 451

2.

The broadening application of chemodenervation in X-linked dystonia-parkinsonism (Part I): muscle afferent block versus botulinum toxin-A in cervical and limb dystonias.

Rosales RL, Santos MM, Ng AR, Teleg R, Dantes M, Lee LV, Fernandez HH.

Int J Neurosci. 2011;121 Suppl 1:35-43. doi: 10.3109/00207454.2010.544435. Epub 2011 Jan 19. Review.

PMID:
21244305
3.

Effect of botulinum toxin treatment on quality of life in patients with isolated lingual dystonia and oromandibular dystonia affecting the tongue.

Nastasi L, Mostile G, Nicoletti A, Zappia M, Reggio E, Catania S.

J Neurol. 2016 Sep;263(9):1702-8. doi: 10.1007/s00415-016-8185-1. Epub 2016 Jun 8.

PMID:
27278063
4.

[Treatment of focal dystonia with botulinum toxin A].

Sojer M, Wissel J, Müller J, Poewe W.

Wien Klin Wochenschr. 2001;113 Suppl 4:6-10. Review. German.

PMID:
15506045
5.

Botulinum toxin A in patients with oromandibular dystonia: long-term follow-up.

Tan EK, Jankovic J.

Neurology. 1999 Dec 10;53(9):2102-7.

PMID:
10599789
6.

[Oromandibular dystonia. Clinical forms, diagnosis and examples of therapy with botulinum toxin].

Laskawi R, Rohrbach S.

Laryngorhinootologie. 2001 Dec;80(12):708-13. German.

PMID:
11793266
7.

Jaw-opening oromandibular dystonia secondary to Wilson's disease treated with botulinum toxin type A.

Teive HA, Klüppel LE, Munhoz RP, Becker N, Müller PR, Werneck LC.

Arq Neuropsiquiatr. 2012 Jun;70(6):407-9.

8.

Oromandibular dystonia: long-term management with botulinum toxin.

Sinclair CF, Gurey LE, Blitzer A.

Laryngoscope. 2013 Dec;123(12):3078-83. doi: 10.1002/lary.23265. Epub 2013 Oct 5.

PMID:
24122897
9.

Successful treatment of open jaw and jaw deviation dystonia with botulinum toxin using a simple intraoral approach.

Moscovich M, Chen ZP, Rodriguez R.

J Clin Neurosci. 2015 Mar;22(3):594-6. doi: 10.1016/j.jocn.2014.08.027. Epub 2014 Dec 23.

PMID:
25541097
10.

Botulinum toxins in the treatment of primary focal dystonias.

Truong D.

J Neurol Sci. 2012 May 15;316(1-2):9-14. doi: 10.1016/j.jns.2012.01.019. Epub 2012 Feb 14. Review.

PMID:
22336699
11.

[Use of botulinum toxin type A in neuro-ORL].

Périé S, Lacau St Guily J.

Ann Readapt Med Phys. 2003 Jul;46(6):375-9. Review. French.

PMID:
12928145
12.

Comparison of botulinum neurotoxin preparations for the treatment of cervical dystonia.

Chapman MA, Barron R, Tanis DC, Gill CE, Charles PD.

Clin Ther. 2007 Jul;29(7):1325-37. Review.

PMID:
17825685
13.

[Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].

Wissel J, Entner T.

Wien Klin Wochenschr. 2001;113 Suppl 4:20-4. Review. German.

PMID:
15506048
14.

[Botulinum toxin type B in the management of dystonia non-responsive to botulinum toxin type A].

Cardoso F.

Arq Neuropsiquiatr. 2003 Sep;61(3A):607-10. Epub 2003 Sep 16. Portuguese.

15.

Treatment of refractory anterior knee pain using botulinum toxin type A (Dysport) injection to the distal vastus lateralis muscle: a randomised placebo controlled crossover trial.

Singer BJ, Silbert PL, Song S, Dunne JW, Singer KP.

Br J Sports Med. 2011 Jun;45(8):640-5. doi: 10.1136/bjsm.2009.069781. Epub 2010 Apr 23.

16.

Secondary nonresponsiveness to botulinum toxin type A in patients with oromandibular dystonia.

Adler CH, Factor SA, Brin M, Sethi KD.

Mov Disord. 2002 Jan;17(1):158-61.

PMID:
11835455
17.

Botulinum toxin type B vs. type A in toxin-naïve patients with cervical dystonia: Randomized, double-blind, noninferiority trial.

Pappert EJ, Germanson T; Myobloc/Neurobloc European Cervical Dystonia Study Group.

Mov Disord. 2008 Mar 15;23(4):510-7.

PMID:
18098274
18.

Lingual protrusion dystonia: frequency, etiology and botulinum toxin therapy.

Esper CD, Freeman A, Factor SA.

Parkinsonism Relat Disord. 2010 Aug;16(7):438-41. doi: 10.1016/j.parkreldis.2010.04.007. Epub 2010 May 21.

PMID:
20494607
19.
20.

Evidence-based review and assessment of botulinum neurotoxin for the treatment of movement disorders.

Hallett M, Albanese A, Dressler D, Segal KR, Simpson DM, Truong D, Jankovic J.

Toxicon. 2013 Jun 1;67:94-114. doi: 10.1016/j.toxicon.2012.12.004. Epub 2013 Feb 4. Review.

PMID:
23380701

Supplemental Content

Support Center